Summary

In any given year, 26.2% of individuals in the United States experience a diagnosable psychiatric illness. Approximately 6% of adults suffer from a seriously debilitating mental illness. Among adolescents aged 13 to 18 years, 46.3% experience symptoms of psychiatric illness, and 21.4% experience a severe disorder. This article discusses clinical tools for personalizing psycho-pharmacologic treatment, including psychopharmacogenetics, laboratory studies, review of systems, symptom evaluation, and observation.